Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiotensins
Study results from M. Tatokoro and colleagues update understanding of angiotensins
October 28th, 2008
"We report three cases of metastatic renal cell carcinoma (RCC) in which combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor (angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor antagonist) (CCA therapy) was effective. Case 1: A 47-year-old man who had a 12-cm right renal tumor with multiple pulmonary and hepatic metastases refused cytokine therapy for economic reasons and received CCA therapy," scientists writing in the International Journal of Urology report. "All of the metastases showed partial remission, which continued for 12 months. Case 2: A 62-year-old man with multiple pulmonary...
Source: Cancer Weekly (2008-10-28)
|
